The package insert (aka drug product label) is the only publicly-available source of
information on drug-drug interactions (DDIs) for some drugs, especially newer ones. Thus,
an automated method for identifying DDIs in drug package inserts would be a potentially
important complement to methods for identifying DDIs from other sources such as the
scientific literature. To develop such an algorithm, we created a corpus of Federal Drug
Administration approved drug package insert statements that have been manually …